Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Shapiro

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Blood|July 1, 1997
Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 geneW P Fay, A C Parker, L R Condrey, et al.
The Journal of Biological Chemistry|June 3, 1994
Rab-GDI presents functional Rab9 to the intracellular transport machinery and contributes selectivity to Rab9 membrane recruitmentA B Dirac-Svejstrup, T Soldati, A D Shapiro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
Type 2B vWD: the varied clinical manifestations in two kindredsP Mathew, A Greist, J A Maahs, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)A A Sharathkumar, J M Soucie, B Trawinski, et al.
The Journal of Cell Biology|May 1, 1994
Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi networkM A Riederer, T Soldati, A D Shapiro, et al.
Blood|January 15, 1994
Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanismsW P Fay, D T Eitzman, A D Shapiro, et al.
American Journal of Hematology|May 1, 1995
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study GroupI Warrier, C K Kasper, G C White, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2017
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitorsC H Miller, B Boylan, A D Shapiro, et al.
The New England Journal of Medicine|December 10, 1992
Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutationW P Fay, A D Shapiro, J L Shih, et al.
Pediatric Dentistry|March 1, 1994
Oral management of a patient with a plasminogen activator inhibitor (PAI-1) deficiency: case reportL K Tanimura, J A Weddell, C G McKown, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Blood|July 1, 1997
Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 geneW P Fay, A C Parker, L R Condrey, et al.
The Journal of Biological Chemistry|June 3, 1994
Rab-GDI presents functional Rab9 to the intracellular transport machinery and contributes selectivity to Rab9 membrane recruitmentA B Dirac-Svejstrup, T Soldati, A D Shapiro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
Type 2B vWD: the varied clinical manifestations in two kindredsP Mathew, A Greist, J A Maahs, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)A A Sharathkumar, J M Soucie, B Trawinski, et al.
The Journal of Cell Biology|May 1, 1994
Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi networkM A Riederer, T Soldati, A D Shapiro, et al.
Blood|January 15, 1994
Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanismsW P Fay, D T Eitzman, A D Shapiro, et al.
American Journal of Hematology|May 1, 1995
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study GroupI Warrier, C K Kasper, G C White, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2017
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitorsC H Miller, B Boylan, A D Shapiro, et al.
The New England Journal of Medicine|December 10, 1992
Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutationW P Fay, A D Shapiro, J L Shih, et al.
Pediatric Dentistry|March 1, 1994
Oral management of a patient with a plasminogen activator inhibitor (PAI-1) deficiency: case reportL K Tanimura, J A Weddell, C G McKown, et al.
Pageof 8